Z-0788-2014 Class I Terminated

Recalled by Codman & Shurtleff, Inc. — Raynham, MA

FDA device recall Z-0788-2014 was initiated by Codman & Shurtleff, Inc. on Oct 11, 2013 and is designated Class I. Reason for recall: Incorrect instructions for use (IFU). The recall status is terminated (terminated Jul 28, 2015). Affected quantity: 3,860.

Recall details

Product Type
Devices
Report Date
Jan 29, 2014
Initiation Date
Oct 11, 2013
Termination Date
Jul 28, 2015
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
3,860

Product description

TRUFILL¿ n-Butyl Cyanoacrylate (n-BCA) Liquid Embolic System; Two 1 g tubes of n-BCA, one 10 mL vial of Ethiodized Oil and one 1 g vial of Tantalum Powder Product Code: 631-400; The TRUFILL n-BCA Liquid Embolic System is indicated for the embolization of cerebral arteriovenous malformations (AVMs) when pre-surgical devascularization is desired.

Reason for recall

Incorrect instructions for use (IFU).

Distribution pattern

Worldwide Distribution: US (nationwide) including Puerto Rico; and internationally to: Costa Rica and Russia.

Code information

All lot codes

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-0788-2014
openFDA file date
Nov 19, 2026
Loaded by RegDataLab
Nov 20, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Need the full FDA record for Codman & Shurtleff, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: openFDA record for Z-0788-2014. Report a data issue: hello@regdatalab.com.